Genervon Biopharmaceuticals LLC Pasadena, CA - 91106

Genervon Biopharmaceuticals LLC is categorized under Commercial Biotechnical Research in Pasadena, CA and active since 2002.

Genervon Biopharmaceuticals LLC was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Winston Ko at the company’s single location by writing to 1055 East Colo Boulevard # 500, Pasadena, California CA 91106 or by phoning (323) 721-5500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genervon Biopharmaceuticals LLC
Contact Person: Winston Ko
Address: 1055 East Colo Boulevard # 500, Pasadena, California 91106
Phone Number: (323) 721-5500
Annual Revenue (USD): $100.000 to $499.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Genervon Biopharmaceuticals LLC was started in 2002 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Winston Ko for inquiries that concern Genervon Biopharmaceuticals LLC by calling the company number (323) 721-5500, as your correspondence is most welcome. Additionally, the physical location of the single location of Genervon Biopharmaceuticals LLC can be found at the coordinates 34.146066,-118.128757 as well as the street address 1055 East Colo Boulevard # 500 in Pasadena, California 91106.

For its online presence, you may visit Genervon Biopharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.